RAGE DIAGNOSTICS LIMITED
Executive Summary
Rage Diagnostics Limited is an early-stage biotechnology research company leveraging specialized expertise and a strategic location within Cambridge's innovation ecosystem. While it currently faces typical start-up financial constraints and market entry challenges, it holds significant growth potential through targeted R&D, strategic partnerships, and access to innovation funding. To realize this potential, the company must address capital limitations, navigate regulatory complexities, and build a diversified leadership and partnership framework.
View Full Analysis Report →- Legal registered address
- Unit 1, Cambridge House Camboro Business Park Oakington Road, Girton Cambridge Cambridgeshire United Kingdom CB3 0QH Copied!
Latest financial results as of 31 August 2025- Cash in bank
- £6.23k
- Current assets
- £31.33k
- Current creditors
- £57.06k
- Shareholders funds
- £-24.79k
View full financial accounts- Cash in bank
- £6.23k
- Current assets
- £31.33k
- Current creditors
- £57.06k
- Shareholders funds
- £-24.79k
- Company number
- 15168724 Copied!
Accounts
Latest annual accounts were to 30 September 2024
Next annual accounts are due by 30 June 2026
Company financial year end is on 30 September 2025
Confirmation statement
Latest confirmation statement statement dated 26 September 2024
Next statement due by 10 October 2025
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Latest company documents
Date | Description |
---|---|
05/06/255 June 2025 | Total exemption full accounts made up to 2024-09-30 |
05/06/255 June 2025 | Previous accounting period shortened from 2024-12-31 to 2024-09-30 |
10/02/2510 February 2025 | Previous accounting period extended from 2024-09-30 to 2024-12-31 |
14/11/2414 November 2024 | Confirmation statement made on 2024-09-26 with updates |
30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company